Related Experiment Videos
[The use of erythropoietin in HIV myelodysplasias. Preliminary study]
L Fruttaldo1, G Gatti, V Deambrogio
1USL n. 76, Ospedale Santo Spirito, Casale Monferrato.
Minerva Medica
|March 1, 1993
The authors gave recombinant human erythropoietin to four anaemic patients with HIV-infection treated with zidovudine. After erythropoietin administration an increase in haemoglobin, erythrocytes and haematocrit was observed and patients could continue AZT therapy.
The authors gave recombinant human erythropoietin to four anaemic patients with HIV-infection treated with zidovudine. After erythropoietin administration an increase in haemoglobin, erythrocytes and haematocrit was observed and patients could continue AZT therapy.